Polio
Approximately seventy-five percent of all polio cases produce no visible symptoms at all. Mild symptoms like sore throat and fever appear in about twenty-four percent of infections. These minor issues usually resolve within one or two weeks. Only one percent of infections allow the virus to migrate into the central nervous system. Most patients with CNS involvement develop nonparalytic aseptic meningitis characterized by headache and neck pain. One to five out of every thousand cases progress to paralytic disease where muscles become weak and floppy. Paralysis most often affects the legs but can involve head neck and diaphragm muscles. Between two and ten percent of those who develop paralysis die because breathing muscles fail. Adults face higher risks than children with paralysis occurring in one out of seventy-five adult cases versus one out of a thousand children. Post-polio syndrome develops decades later in between twenty-five and fifty percent of survivors. This condition brings slow muscle weakness similar to the initial infection without any infectious process involved.
Egyptian steles from the eighteenth dynasty depict people with withered limbs suggesting ancient awareness of the disease. The earliest known case involves remains of a teenage girl found in a four-thousand-year-old burial site in the United Arab Emirates. English physician Michael Underwood provided the first clinical description in seventeen-eighty-nine calling it debility of lower extremities. Major outbreaks began appearing in Europe and the United States around nineteen-hundred. By nineteen-fifty-two the peak age for paralytic poliomyelitis shifted from infants to children aged five to nine years. That year nearly fifty-eight thousand cases were reported in the United States alone with over three thousand deaths. The World Health Organization launched the Global Polio Eradication Initiative in nineteen-eighty-eight. Cases dropped from an estimated three hundred fifty thousand that year to just thirty confirmed wild virus cases by two thousand twenty-two. Wild poliovirus type two was certified eradicated in two thousand fifteen while type three followed suit in two thousand nineteen. Only Pakistan and Afghanistan remain endemic for wild poliovirus as of recent reports.
Jonas Salk developed the inactivated polio vaccine at the University of Pittsburgh in nineteen-fifty-two. He announced his success to the world on April twelfth nineteen-fifty-five using monkey kidney tissue cultures. Albert Sabin later created an oral polio vaccine containing weakened live virus produced through repeated passage through nonhuman cells. Human trials of Sabin's vaccine began in nineteen-fifty-seven and it received licensure in nineteen-sixty-two. Three doses of the oral vaccine produce protective antibody to all three serotypes in more than ninety-five percent of recipients. In communities with low coverage the attenuated virus can mutate and revert to a virulent form causing circulating vaccine-derived poliovirus. An improved novel oral polio vaccine type two gained full licensure in December two-thousand-and-twenty-three. This newer version has greater genetic stability and is less likely to cause paralysis. The Global Polio Eradication Initiative raised eighteen billion dollars in funding since its inception. Annual contributions now range between eight hundred million and one billion dollars from various global sources including the Gates Foundation.
No cure exists for polio but supportive measures help manage symptoms and prevent complications. Portable ventilators support breathing when respiratory muscles fail. Historically iron lungs provided artificial respiration until patients could breathe independently again. These devices are largely obsolete today due to modern alternatives and disease reduction. Hydrotherapy electrotherapy massage and passive motion exercises formed early treatment approaches. Surgical options include tendon lengthening nerve grafting and corrective shoes or braces. Orthotics with stance phase control knee joints help restore natural gait patterns despite mechanical limitations. Muscle paresis often leads to skeletal deformities like equinus foot requiring specialized footwear or surgery. Extended wheelchair use may cause compression neuropathy and loss of proper vein function in paralyzed limbs. Complications from prolonged immobility include pulmonary edema aspiration pneumonia kidney stones and myocarditis. Physical therapy occupational therapy and orthopedic surgery remain essential components of long-term rehabilitation strategies for survivors worldwide.
Continue Browsing
Common questions
What is the size and structure of a poliovirus particle?
A single poliovirus particle measures thirty nanometers across. It carries a simple RNA genome wrapped in a protein shell called a capsid.
How does polio transmission occur and when does it peak in different climates?
Transmission occurs primarily through the fecal-oral route via contaminated food or water with occasional oral-oral transmission. In temperate climates peak transmission occurs during summer and autumn months while tropical areas show far less seasonal variation.
What percentage of polio cases result in paralysis and what are the mortality rates for adults versus children?
One to five out of every thousand cases progress to paralytic disease where muscles become weak and floppy. Adults face higher risks than children with paralysis occurring in one out of seventy-five adult cases versus one out of a thousand children.
When was the Global Polio Eradication Initiative launched and how many wild virus cases remained by 2022?
The World Health Organization launched the Global Polio Eradication Initiative in nineteen-eighty-eight. Cases dropped from an estimated three hundred fifty thousand that year to just thirty confirmed wild virus cases by two thousand twenty-two.
Who developed the first polio vaccine and when did Jonas Salk announce his success?
Jonas Salk developed the inactivated polio vaccine at the University of Pittsburgh in nineteen-fifty-two. He announced his success to the world on April twelfth nineteen-fifty-five using monkey kidney tissue cultures.